Adiponectin concentrations during menstrual cycle;Variación de adiponectina en el ciclo menstrual

Ginecologia y Obstetricia de Mexico

Volumn 75, Issue 8, 2007, Pages 435-438

  Galván, Rosa E ^a   Basurto, Lourdes ^a   Saucedo, Renata ^a   Campos, Sandra ^a   Hernández, Marcelino ^a   Zárate, Arturo ^a,b  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b Hospital de Mexico   (Mexico)

Author keywords

Adiponectin; Menstrual cycle; Sexual steroids

Indexed keywords

ADIPONECTIN; ESTRADIOL; FOLLITROPIN; INSULIN; LUTEINIZING HORMONE; PROGESTERONE; SEX HORMONE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE ACTION; HORMONE RELEASE; HUMAN; INSULIN RESISTANCE; MENSTRUAL CYCLE;

ADIPONECTIN; ADULT; ESTRADIOL; FEMALE; HUMANS; MENSTRUAL CYCLE; PROGESTERONE;

EID: 35448976095     PISSN: 03009041     EISSN: 03009041     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Ouchi N, Kihara S, Arita Y, Maeda K, et al. Novel modulator for endotelial adhesión molecules: adipocyte-derived plasma protein, adiponectin. Circulation 1999;100:2473-76.
2. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, et al. Circulating concentrations of the adypocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during progression to type 2 diabetes in rhesus monkeys. Diabetes 2001;50:1126-33.
3. Arita Y, Kihara S, Ouchi N, Takahashi M, et al. Paradoxical decrease of a adipose-specific protein, adiponectin, obesity. Biochem Biophys Res Commun 1999;257:79-83.
4. Hotta K, Funahashi T, Arita Y, Takahashi M, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-99.
5. Ardawi MS, Rouzii AA. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2005;83:1708-16.
6. Sieminska L, Wojciechowska C, Foltyn W, Kajdaniuk D, et al. The relation of serum adiponectin and leptin levels to metabolic syndrome in women before and after menopause. Endokrynol Pol 2006;57:15-22.
7. Chu MC, Cosper P, Orio F, Carmina E, Lobo RA. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin and ghrelin. Am J Obstet Gynecol 2006;194:100-4.
8. Nishizawa H, Shimomura I, Kishida K, Maeda N, et al. Androgens decrease plasma adiponectin an insulin-sensitizing adipocyte-derived protein. Diabetes 2002;51:2734-41.
9. Kleiblova P, Springer D, Haluzik M. The influence of hormonal changes during menstrual cycle on serum adiponectin concentrations in healthy women. Physiol Res 2006;55:661-66.
10. Combs TP, Berg AH, Rajala MW, Klevanov S, et al. Sexual differentiation, pregnancy, caloric restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003;52:268-76.
11. Saucedo R, Basurto L, Zarate A, Martinez C, et al. Effect of estrogen therapy on insulin resistance and plasminogen activator inhibitor type 1 concentration in postmenopausal women. Gynec Obstet Invest 2007; 64:61-64.
12. Zárate A, Saucedo R. Un análisis de la ubicación clínica del síndrome metabólico. Gac Med Méx 2006;142:27-30.
13. Zárate A, Saucedo R, Basurto L, Hernández M. Síndrome metabólico en la menopausia. En: Delgado UJ, Fernández del Castillo C. Ginecología y reproducción humana. Temas Selectos. Tomo II. México: Colegio Mexicano de Especialistas en Ginecología y Obstetricia, 2006;pp: 93-100.
14. Bruns CM, Kemnitz JW. Sex hormones, insulin sensitivity, and diabetes mellitus. ILAR J 2004;45:160-69.